DE69637078D1 - Polypeptid-fragmente die fähig sind mit dem antigen i/ii von streptococcus mutans zu konkurrieren - Google Patents

Polypeptid-fragmente die fähig sind mit dem antigen i/ii von streptococcus mutans zu konkurrieren

Info

Publication number
DE69637078D1
DE69637078D1 DE69637078T DE69637078T DE69637078D1 DE 69637078 D1 DE69637078 D1 DE 69637078D1 DE 69637078 T DE69637078 T DE 69637078T DE 69637078 T DE69637078 T DE 69637078T DE 69637078 D1 DE69637078 D1 DE 69637078D1
Authority
DE
Germany
Prior art keywords
antigen
streptococcus
mutanean
competing
polypeptide fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69637078T
Other languages
English (en)
Other versions
DE69637078T2 (de
Inventor
Thomas Lehner
Charles Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Application granted granted Critical
Publication of DE69637078D1 publication Critical patent/DE69637078D1/de
Publication of DE69637078T2 publication Critical patent/DE69637078T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
DE69637078T 1995-01-31 1996-01-31 Polypeptid-fragmente die fähig sind mit dem antigen i/ii von streptococcus mutans zu konkurrieren Expired - Fee Related DE69637078T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9501826 1995-01-31
GBGB9501826.3A GB9501826D0 (en) 1995-01-31 1995-01-31 Polypeptide fragments
PCT/GB1996/000207 WO1996023886A1 (en) 1995-01-31 1996-01-31 Polypeptide fragments capable of competition with streptococcus mutans antigen i/ii

Publications (2)

Publication Number Publication Date
DE69637078D1 true DE69637078D1 (de) 2007-06-21
DE69637078T2 DE69637078T2 (de) 2008-01-10

Family

ID=10768834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637078T Expired - Fee Related DE69637078T2 (de) 1995-01-31 1996-01-31 Polypeptid-fragmente die fähig sind mit dem antigen i/ii von streptococcus mutans zu konkurrieren

Country Status (8)

Country Link
US (2) US6024958A (de)
EP (1) EP0871734B1 (de)
AT (1) ATE361980T1 (de)
AU (1) AU4545096A (de)
DE (1) DE69637078T2 (de)
ES (1) ES2285709T3 (de)
GB (1) GB9501826D0 (de)
WO (1) WO1996023886A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US6923962B2 (en) * 2000-04-10 2005-08-02 Dennis Cvitkovitch Signal peptides, nucleic acid molecules and methods for treatment of caries
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US8876532B2 (en) 2002-07-31 2014-11-04 Dentsply International Inc. Bone repair putty
EP1634948A1 (de) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Mittel und Verfahren zur Vorbeugung und/oder Behandlung von Karies
US9127045B2 (en) * 2005-11-17 2015-09-08 University Of Southern California Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides
WO2007079755A1 (en) * 2006-01-12 2007-07-19 Janus Beierholm Holding Aps Reimmunization and antibody design
EP2463306A1 (de) 2006-05-02 2012-06-13 Carviar ApS Verfahren zur Immunisierung einer Geflügelspezies
KR101432336B1 (ko) 2006-12-19 2014-08-20 바스프 에스이 뮤탄스 연쇄상구균에 의해 유발된 우식증의 예방 및/또는 치료를 위한 용도 및 방법
EP2418284A1 (de) * 2010-08-13 2012-02-15 ERA Biotech, S.A. Polypeptidsequenzen zur Induzierung von Proteinkörpern

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2060647B (en) * 1979-10-18 1983-04-13 Russell M W Antigens ex streptococcus mutans
GB8303994D0 (en) * 1983-02-14 1983-03-16 Council Of Governors Of United Antigenic materials
US5258368A (en) * 1984-04-19 1993-11-02 Scios Nova, Inc. Atrial natriuretic/vasodilator peptide compounds
GB8704647D0 (en) * 1987-02-27 1987-04-01 Guy S & St Thomas S Hospitals Vaccine

Also Published As

Publication number Publication date
ES2285709T3 (es) 2007-11-16
AU4545096A (en) 1996-08-21
WO1996023886A1 (en) 1996-08-08
DE69637078T2 (de) 2008-01-10
US6500433B1 (en) 2002-12-31
US6024958A (en) 2000-02-15
GB9501826D0 (en) 1995-03-22
ATE361980T1 (de) 2007-06-15
EP0871734B1 (de) 2007-05-09
EP0871734A1 (de) 1998-10-21

Similar Documents

Publication Publication Date Title
NO20001104D0 (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende slike samt terapeutiske anvendelser derav
HUP9702458A2 (hu) Humán interleukin-1-receptor járulékos fehérje
NO982062D0 (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav
DK0825847T3 (da) Tandrensningspræparater
DE69637078D1 (de) Polypeptid-fragmente die fähig sind mit dem antigen i/ii von streptococcus mutans zu konkurrieren
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
AU4230493A (en) Diphtheria toxin receptor-binding region
EA199800946A1 (ru) Концентрированный препарат антител
IT8219538A0 (it) Composizione cosmetica dimagrante e anticellulitica.
AU7095887A (en) Human gamma interferon-specific receptor protein, antibody against said protein and said antibody and compositions containing said protein and antibody
BR9809656A (pt) Composição imunopotencializante
AUPN627595A0 (en) Diagnostics and treatments of periodontal disease
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
DK0954529T3 (da) Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse
AU7970894A (en) Method of treating depressed reticuloendothelial system function
ATE284201T1 (de) Fluoridfreie zahnremineralisierung
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
ATE155345T1 (de) Gegengift immunsera
ITTO940790A0 (it) Composizione cosmetica e procedimento di trattamento estetico che con trasta l'invecchiamento della pelle.
DK392288A (da) Human monoklonale antistoffer samt profylaktiske og terapeutiske midler mod infrektioese sygdomme, der indeholder samme som aktiv bestanddel
EP0836480A4 (de) Zusammensetzungen, welche adp-ribosyltransferase-aktivität ausweisen und methoden für ihre herstellung und die verwendung derselben
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
IT8719180A0 (it) Composizione cosmetica.
MA21243A1 (fr) Shampooing doux .

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee